Federal lawmakers have recently taken steps to ensure that the policy response to the opioid crisis is not influenced by advocacy groups with financial ties to the opioid industry.1,2 However, whether members of Congress might have relevant conflicts of interest stemming from financial ties to the opioid industry is unknown. Although advocacy groups can influence policy only indirectly, members of Congress oversee federal agencies and are directly responsible for crafting legislation to address the opioid crisis. In particular, members of the Senate Health, Education, Labor, and Pensions (HELP) Committee and the House Energy and Commerce Committee have led the Senate and House responses to the crisis.
McCoy MS, Kanter GP. Campaign Contributions From Political Action Committees to Members of Congressional Committees Responding to the Opioid Crisis. JAMA. 2018;320(14):1489–1491. doi:10.1001/jama.2018.11338
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: